Jump to content
RemedySpot.com

FDA OKs Bristol-Myers Squibb Company (BMY) Rheumatoid Arthritis Drug

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 05

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

PRINCETON, N.J., Dec. 23 /PRNewswire-FirstCall/-- Bristol-Myers Squibb

Company (NYSE: BMY - News) announced today that the U.S. Food and Drug

Administration (FDA) has approved ORENCIA® (abatacept), the first

selective modulator of a co-stimulatory signal required for full T-cell

activation, for the treatment of rheumatoid arthritis (RA).

http://www.biospace.com/news_story.aspx?StoryID=5703

New drug...too bad its another IV drug...but at least its once a month

and given over 30 minutes.

Toni

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...